These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 37240346

  • 1. Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
    Ciapała K, Rojewska E, Pawlik K, Ciechanowska A, Mika J.
    Int J Mol Sci; 2023 May 19; 24(10):. PubMed ID: 37240346
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
    Popiolek-Barczyk K, Makuch W, Rojewska E, Pilat D, Mika J.
    Pharmacol Rep; 2014 Oct 19; 66(5):845-51. PubMed ID: 25149989
    [Abstract] [Full Text] [Related]

  • 3. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
    Ciechanowska A, Rojewska E, Piotrowska A, Barut J, Pawlik K, Ciapała K, Kreiner G, Mika J.
    Front Immunol; 2022 Oct 19; 13():1058204. PubMed ID: 36618360
    [Abstract] [Full Text] [Related]

  • 4. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K, Pawlik K, Ciapała K, Piotrowska A, Makuch W, Mika J.
    Front Immunol; 2020 Oct 19; 11():615327. PubMed ID: 33408720
    [Abstract] [Full Text] [Related]

  • 5. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K, Popiolek-Barczyk K, Piotrowska A, Rojewska E, Ciapała K, Makuch W, Mika J.
    Cytokine; 2019 Jul 19; 119():202-213. PubMed ID: 31003094
    [Abstract] [Full Text] [Related]

  • 6. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model.
    Rojewska E, Ciapała K, Mika J.
    Pharmacol Rep; 2019 Feb 19; 71(1):139-148. PubMed ID: 30550994
    [Abstract] [Full Text] [Related]

  • 7. PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.
    Rojewska E, Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Zychowska M, Makuch W, Przewlocka B, Mika J.
    PLoS One; 2015 Feb 19; 10(10):e0138583. PubMed ID: 26426693
    [Abstract] [Full Text] [Related]

  • 8. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K, Ciechanowska A, Ciapała K, Rojewska E, Makuch W, Mika J.
    Front Immunol; 2021 Feb 19; 12():781310. PubMed ID: 34795678
    [Abstract] [Full Text] [Related]

  • 9. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
    Bogacka J, Ciapała K, Pawlik K, Kwiatkowski K, Dobrogowski J, Przeklasa-Muszynska A, Mika J.
    Front Immunol; 2020 Feb 19; 11():1241. PubMed ID: 32760393
    [Abstract] [Full Text] [Related]

  • 10. Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain.
    Ciapała K, Pawlik K, Ciechanowska A, Mika J, Rojewska E.
    Toxicol Appl Pharmacol; 2023 Feb 15; 461():116382. PubMed ID: 36681127
    [Abstract] [Full Text] [Related]

  • 11. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-Kaim A, Mika J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan 04; 64():68-78. PubMed ID: 26190414
    [Abstract] [Full Text] [Related]

  • 12. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
    Zhao X, Li XL, Liu X, Wang C, Zhou DS, Ma Q, Zhou WH, Hu ZY.
    Pharmacol Res; 2015 Dec 04; 102():286-97. PubMed ID: 26520392
    [Abstract] [Full Text] [Related]

  • 13. Behavioral effects of combined morphine and MK-801 administration to the locus coeruleus of a rat neuropathic pain model.
    Llorca-Torralba M, Mico JA, Berrocoso E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun 08; 84(Pt A):257-266. PubMed ID: 29524514
    [Abstract] [Full Text] [Related]

  • 14. Nrf2 Activation Attenuates Chronic Constriction Injury-Induced Neuropathic Pain via Induction of PGC-1α-Mediated Mitochondrial Biogenesis in the Spinal Cord.
    Sun J, Li JY, Zhang LQ, Li DY, Wu JY, Gao SJ, Liu DQ, Zhou YQ, Mei W.
    Oxid Med Cell Longev; 2021 Jun 08; 2021():9577874. PubMed ID: 34721761
    [Abstract] [Full Text] [Related]

  • 15. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J, Popiolek-Barczyk K, Pawlik K, Ciechanowska A, Makuch W, Rojewska E, Dobrogowski J, Przeklasa-Muszynska A, Mika J.
    Eur J Pharmacol; 2020 Aug 05; 880():173166. PubMed ID: 32407723
    [Abstract] [Full Text] [Related]

  • 16. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
    Pawlik K, Piotrowska A, Kwiatkowski K, Ciapała K, Popiolek-Barczyk K, Makuch W, Mika J.
    Immunology; 2020 Apr 05; 159(4):413-428. PubMed ID: 31919846
    [Abstract] [Full Text] [Related]

  • 17. Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics.
    Ciapała K, Mika J.
    Pharmaceuticals (Basel); 2023 Nov 17; 16(11):. PubMed ID: 38004489
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-κB pathways.
    Zhao L, Tao X, Song T.
    Eur J Pharmacol; 2021 Dec 05; 912():174575. PubMed ID: 34673033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.